VTVT


vTv Therapeutics (VTVT) Stock: Healthcare Analysts Move to the Sidelines

Last week, vTv Therapeutics Inc (NASDAQ:VTVT) announced that azeliragon, the company’s RAGE inhibitor in development for Alzheimer’s disease (AD) failed in Part A …

What Spooked vTv Therapeutics (VTVT) and Selecta Biosciences (SELB) Investors

vTv Therapeutics Collapses as Alzheimer’s Disease Drug Missed Primary Endpoint It’s a short and dramatic plunge for vTv Therapeutics Inc (NASDAQ:VTVT). Today, the drug …